WASHINGTON (Reuters) – Mylan NV’s move on Thursday to expand discount programs for its EpiPen allergy treatment was welcome but not sufficient, a spokesman for U.S. Democratic presidential candidate Hillary Clinton said in a statement.
ResMed Inc said on Thursday it has filed legal action to stop the alleged infringement of its patented technology by New Zealand-based medical device manufacturer Fisher & Paykel Healthcare. ResMed said in a statement it filed legal action with the U.S. International Trade Commission and the U.S. District Court for the Southern District of California in San Diego, as well as courts in New Zealand and Germany. ResMed is calling for an injunction banning importation of Fisher & Paykel Simplus full face mask, Eson nasal mask and Eson 2 nasal mask.
(Reuters) – Tests showed music superstar Prince, who was found dead in his home in a Minneapolis suburb in late April, died of an opioid overdose, the Associated Press reported on Thursday, citing a law enforcement official. (Reporting by Megan Cassella in Washington; Editing by Mohammad Zargham)
JEFFERSON CITY, Mo. (AP) — A new Missouri law offered a first-of-its-kind solution to the physician shortage plaguing thousands of U.S. communities: Medical school graduates could start treating patients immediately, without wading through years of traditional residency programs.
An unlicensed Cambodian doctor was sentenced to 25 years in prison on Thursday after he was found guilty of infecting more than 200 people with HIV, including some who later died.
KATHMANDU, Nepal (AP) — Shortages of life-saving medicine because of political protests in Nepal that have blocked key roads could lead to a crisis, as hospitals have started to cut services, doctors said Thursday.
By Deena Beasley LOS ANGELES (Reuters) – Gilead Sciences Inc on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. Gilead signaled that, with its hepatitis C franchise established, it is a good time for the company to consider business development opportunities. “We want to stick very closely to therapeutic areas we are in today,” Gilead Chief Operating Officer John Milligan said on a conference call. Excluding items, Gilead earned $2.94 per share in the first quarter, beating the average Wall Street estimate of $2.32, according to Thomson Reuters I/B/E/S. The company’s shares, which fell 1.8 percent in regular trading, rose 2 percent to $102.52 after hours.
NEW YORK (AP) — Teen smoking hit a new low last year while the popularity of electronic cigarettes and water pipes boomed, a government report shows.
(Reuters) – The U.S. Supreme Court allowed Oklahoma to proceed with an execution planned for Thursday, which would be the state’s first since a flawed execution in April 2014 led to widespread criticism. In a decision released on Thursday, the court denied an appeal for a stay, with four of the nine justices dissenting. Oklahoma plans to execute convicted murderer and rapist Charles Warner later on Thursday. (Reporting by Jon Herskovitz; Editing by Eric Walsh)